Stocks and Investing Stocks and Investing
Wed, January 22, 2020
Tue, January 21, 2020

Mani Foroohar Initiated (ARWR) at Sell and Held Target at $32 on, Jan 21st, 2020


Published on 2024-10-26 20:27:51 - WOPRAI, Mani Foroohar
  Print publication without navigation


Mani Foroohar of SVB Leerink, Initiated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Sell and Held Target at $32 on, Jan 21st, 2020.

Mani has made no other calls on ARWR in the last 4 months.



There are 5 other peers that have a rating on ARWR. Out of the 5 peers that are also analyzing ARWR, 2 agree with Mani's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Esther Rajavelu of "Oppenheimer" Initiated at Hold on, Friday, December 13th, 2019
  • Elemer Piros of "Cantor Fitzgerald" Maintained at Hold with Increased Target to $50 on, Tuesday, November 19th, 2019


These are the ratings of the 3 analyists that currently disagree with Mani


  • Joel Beatty of "Baird" Upgraded from Hold to Buy and Increased Target to $70 on, Monday, November 25th, 2019
  • Madhu Kumar of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $59 on, Wednesday, November 13th, 2019
  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy with Increased Target to $45 on, Tuesday, October 22nd, 2019

Contributing Sources